The Technical Analyst
Select Language :
Compass Therapeutics, [CMPX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Compass Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Compass Therapeutics, is listed at the  Exchange

-3.41% $1.980

America/New_York / 28 mar 2024 @ 16:00


Compass Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 252.42 mill
EPS: -0.330
P/E: -6.00
Earnings Date: Mar 21, 2024
SharesOutstanding: 127.49 mill
Avg Daily Volume: 0.508 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -6.00 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.02x
Company: PE -6.00 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.304
(-84.63%) $-1.676
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.818 - 2.14

( +/- 8.18%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-08 Boylan James P Buy 40 000 Stock Option (Right to Buy)
2024-02-09 Gray Mary Ann Buy 40 000 Stock Option (Right to Buy)
2024-02-09 Lindahl Richard S Buy 40 000 Stock Option (Right to Buy)
2024-02-09 Gordon Carl L Buy 40 000 Stock Option (Right to Buy)
2024-02-09 Chiniara Ellen Buy 40 000 Stock Option (Right to Buy)
INSIDER POWER
94.03
Last 94 transactions
Buy: 28 287 388 | Sell: 226 920

Forecast: 16:00 - $1.980

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.980
Forecast 2: 16:00 - $1.980
Forecast 3: 16:00 - $1.980
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.980 (-3.41% )
Volume 0.141 mill
Avg. Vol. 0.508 mill
% of Avg. Vol 27.79 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Compass Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Compass Therapeutics, Inc.

RSI

Intraday RSI14 chart for Compass Therapeutics, Inc.

Last 10 Buy & Sell Signals For CMPX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 12 - 12:31buy$1.795N/AActive
Profile picture for
            Compass Therapeutics, Inc.

CMPX

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
NEOUSDMar 28 - 20:18$16.08
KDAUSDMar 28 - 20:17$1.450
CHZUSDMar 28 - 20:18$0.145
BAKEUSDMar 28 - 20:17$0.452
AGLDUSDMar 28 - 20:181.640
SETHUSDMar 28 - 20:133 555.38
GRAILUSDMar 28 - 20:162 188.89
BOBAUSDMar 28 - 20:160.582
XTZUSDMar 28 - 20:15$1.401
SUPERUSDMar 28 - 20:14$1.359

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.